ClearPoint Neuro (CLPT) Projected to Post Earnings on Wednesday

ClearPoint Neuro (NASDAQ:CLPT) is expected to release its earnings data after the market closes on Wednesday, February 26th. Analysts expect ClearPoint Neuro to post earnings of ($0.15) per share and revenue of $8.23 million for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link.

ClearPoint Neuro Stock Down 4.2 %

CLPT opened at $16.72 on Monday. The company has a market capitalization of $461.14 million, a price-to-earnings ratio of -24.23 and a beta of 1.03. The firm has a 50-day moving average price of $16.61 and a 200-day moving average price of $13.67. ClearPoint Neuro has a twelve month low of $5.11 and a twelve month high of $19.22.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on CLPT. Lake Street Capital lifted their target price on shares of ClearPoint Neuro from $17.00 to $30.00 and gave the stock a “buy” rating in a research note on Tuesday, January 21st. B. Riley lifted their target price on shares of ClearPoint Neuro from $15.00 to $20.00 and gave the stock a “buy” rating in a research note on Tuesday, January 28th.

About ClearPoint Neuro

ClearPoint Neuro, Inc operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain.